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Abstract
Background: Recombinant DNA technologies have played a pivotal role in the elucidation of structure-function
relationships in hemoglobin (Hb) and other globin proteins. Here we describe the development of a plasmid expression
system to synthesize recombinant Hbs in Escherichia coli, and we describe a protocol for expressing Hbs with low intrinsic
solubilities. Since the a- and b-chain Hbs of different species span a broad range of solubilities, experimental protocols that
have been optimized for expressing recombinant human HbA may often prove unsuitable for the recombinant expression
of wildtype and mutant Hbs of other species.
Methodology/Principal Findings: As a test case for our expression system, we produced recombinant Hbs of the deer
mouse (Peromyscus maniculatus), a species that has been the subject of research on mechanisms of Hb adaptation to
hypoxia. By experimentally assessing the combined effects of induction temperature, induction time and E. coli expression
strain on the solubility of recombinant deer mouse Hbs, we identified combinations of expression conditions that greatly
enhanced the yield of recombinant protein and which also increased the efficiency of post-translational modifications.
Conclusion/Significance: Our protocol should prove useful for the experimental study of recombinant Hbs in many non-
human animals. One of the chief advantages of our protocol is that we can express soluble recombinant Hb without co-
expressing molecular chaperones, and without the need for additional reconstitution or heme-incorporation steps.
Moreover, our plasmid construct contains a combination of unique restriction sites that allows us to produce recombinant
Hbs with different a- and b-chain subunit combinations by means of cassette mutagenesis.
Citation: Natarajan C, Jiang X, Fago A, Weber RE, Moriyama H, et al. (2011) Expression and Purification of Recombinant Hemoglobin in Escherichia coli. PLoS
ONE 6(5): e20176. doi:10.1371/journal.pone.0020176
Editor: Michael Hofreiter, University of York, United Kingdom
Received October 20, 2010; Accepted April 26, 2011; Published May 20, 2011
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This work was funded by National Science Foundation Grant DEB-0614342 (http://www.nsf.gov/); and National Institutes of Health/National Heart,
Lung, and Blood Institute Grant R01 HL087216 (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jstorz2@unl.edu
Introduction
Hemoglobin (Hb) and myoglobin (Mb) have long held center
stage in studies of the relationship between protein structure and
protein function. Hb and Mb were the first proteins whose
structures were solved at high resolution by X-ray crystallography,
and Hb has served as a highly profitable model system for
establishing principles of allosteric regulation [1,2,3,4]. In the last
few decades, our understanding of structure-function relationships
has been greatly aided by the ability to introduce specific
mutations into recombinant proteins by site-directed mutagenesis
[5,6,7,8,9]. In the case of human embryonic Hbs, our under-
standing of structure-function relationships is solely based on
experimental studies of recombinant proteins [10]. The expression
and functional analysis of recombinant Hbs (rHbs) has also
provided detailed insights into molecular mechanisms of patho-
physiology and biochemical adaptation. For example, site-directed
mutagenesis of human rHbs revealed the molecular mechanism
responsible for elevated Hb-O2 affinity in birds that are capable of
high-altitude flight [11,12]. Similarly, mutagenesis studies of
human rHbs also aided the identification of sites responsible for
the binding of bicarbonate ions as allosteric effectors in crocodile
Hb [13]. By using ancient DNA as source material, this
experimental approach has even provided insights into functional
properties of Hb from extinct animals [14].
Recent advances in molecular biology have led to the
development of increasingly refined and efficient methods for
producing rHb. Some of these methodological improvements have
been motivated by the goal of developing cell-free, rHb-based
blood substitutes [15]. Nagai and Thøgersen [16,17] developed
the first bacterial expression system for producing rHbs in E. coli.
These first efforts involved fusing a-o rb-globin cDNAs to the
coding region of a bacteriophage repressor gene. The insoluble
fusion protein could then be digested to recover the intact globin
chain [18]. One drawback of this system was that, once recovered,
the globins had to be reconstituted in vitro with heme. A second-
generation expression system involved co-expressing the a-o rb-
globin genes as a polycistronic transcript with tac promoter [19]. In
this system, functional Hb tetramers were produced after the
incorporation of exogenous heme in the E. coli cytoplasm. One
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such that the N-terminal methionine residue was not cleaved from
the a-a n db-chain polypeptides. Two strategies have been adopted
to solve this problem [19]. One strategy involves altering the first
codon so that valine is substituted for the initiator methionine. The
second strategy involves co-expressing the gene for methionine
aminopeptidase (MAP), an enzyme that cleaves the N-terminal
methionine from the nascent globin chains in E. coli [20,21]. In the
polycistronic approach the a- and b-globin genes were successfully
co-expressed with the MAP gene under the control of two separate
tacpromoters[22].Expressionofa-globinasa solublefusion protein
with exogenous heme has been attempted in bacteria, but
expression and isolation proved to be more difficult than in the
case of b-globin [23]. Vasseur-Godbillonn et al. [24] were able to
improve the yield of soluble a-globin in E. coli by co-expressing the
gene for the a-Hb stabilizing protein (AHSP), an erythroid-specific
chaperone protein that binds specifically to free a-globin and
prevents its precipitation [25,26].
In the present report we describe modifications of expression
conditions that increase the solubility of rHb and which also
enhance the efficiency of post-translational modifications in E. coli.
We identified optimal combinations of temperature, induction
time, and expression strain for the efficient expression of soluble
rHbs with proper cleaving of N-terminal methionine residues. The
purified rHbs can be used for any number of downstream
applications including structural and functional studies. Moreover,
the protocol that we describe can be executed using resources of a
standard molecular biology laboratory.
Methods
Study system
As a test case for our expression system, we produced rHbs of
the deer mouse, Peromyscus maniculatus. Deer mice have served as
subjects for extensive research on mechanisms of Hb adaptation to
high-altitude hypoxia [27,28,29,30,31]. Highland and lowland
populations of deer mice possess structurally distinct Hbs due to
allelic variation at two tandemly duplicated a-globin genes and
two tandemly duplicated b-globin genes. We refer to the high- and
low-altitude a-globin sequences as Ha and La, respectively, and
we refer to the high- and low-altitude b-globin sequences as Hb
and Lb, respectively. With regard to the a-chain subunits, the Ha
and La sequences differ at eight amino acid positions:
50(CD8)Pro/His, 57(E6)Gly/Ala, 60(E9)Ala/Gly, 64(E13)Gly/
Asp, 71(E20)Ser/Gly, 113(GH1)His/Leu, 115(GH3)Ala/Ser, and
116(GH4)Glu/Asp (the notation in parentheses indicates the
sequential number of each residue in a-helices A-H, the
interhelical segments, or terminal extensions). With regard to the
b-chain subunits, the Hb and Lb sequences differ at four amino
acid positions: 62(E6)Gly/Ala, 72(E16)Gly/Ser, 128(H6)Ala/Ser,
and 135(H13)Ala/Ser. To measure the net contributions of the a-
and b-globin mutations to variation in Hb-O2 affinity, we
synthesized the high- and low-altitude ‘wildtype’ isoHbs, Ha2Hb2
and La2Lb2, which we henceforth refer to as ‘HH’ and ‘LL’.
Preparation of plasmid DNA
We constructed two expression plasmids, pGM-HaHb and
pGM-LaLb, which contain the a- and b-globin sequences that are
charactistic of high- and low-altitude mice, respectively. The a/b-
globin and MAP cassettes were synthesized by Genscript (Piscat-
away, NJ, USA). DNA sequences of the a- and b-globin genes
were optimized with respect to E. coli codon preferences in order to
maximize translational efficiency [23,32]. The a- and b-globin
genes were tandemly cloned with a Shine-Dalgarno ribosomal
binding site as an intergenic spacer [19]. In addition to expressing
the a- and b-globin genes, the pGM plasmid also expresses the
MAP gene under the control of a second independent T7
promoter (Figure 1a). The MAP enzyme is responsible for
cleaving the N-terminal methionine residues from the nascent
globin chains, a critical post-translational modification of tetra-
meric Hb. We also co-expressed a pCO-MAP plasmid that
contained an additional copy of the MAP gene with kanamycin
resistance to provide a means of antibiotic selection (Figure 1b).
Alternative a-globin genes can be swapped by using two unique
Figure 1. Design of the expression plasmids. As shown in Panel A, the pGM-HaHb plasmid system contains a cassette of tandemly arrayed a-
and b-globin genes with a Shine-Dalgarno ribosomal binding site as a spacer DNA. The MAP cassette is located downstream of b-globin. As shown in
panel B, the pCO-MAP plasmid contains a MAP cassette under the control of a T7 promoter along with a kanamycin resistance gene.
doi:10.1371/journal.pone.0020176.g001
Expression of rHbs in E.coli
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genes can be swapped by using a different pair of unique
restriction enzymes, NdeI and SacI.
Optimization of expression conditions
Using the deer mouse pGM-HaHb construct as a test case, we
sought to increase the solubility of rHb by optimizing the expression
conditions. Specifically, we conducted experiments to assess the
combined effects of temperature, induction time, E. coli expression
strain to enhance solubility and to improve the efficiencies of heme
incorporation and post-translational modifications of deer mouse
rHbs. The pGM-HaHb plasmid was transformed into five
commercially available expression strains: JM109 (DE3), BL21
(DE3) pLysS, BL21Star
TM (DE3), BLR (DE3), and Origami
TM
(DE3). The E. coli cells were induced with 0.2 mM IPTG for 4 hr at
30uC in an orbital shaker at 200 rpm. The rHb samples were
subsequently analyzed by 16% SDS-PAGE and yields were
quantified by densitometric measures using the program Quantity
One(BioRad,Hercules,CA,USA).Wealsoevaluatedfour different
combinations of temperature and induction time for the optimiza-
tion of rHb expression: (1) 12uC for 24 hr, (2) 25uC for 16 hr, (3)
30uC for 4 hr, and (4) 37uC for 4 hr. As before, the samples were
analyzed by 16% SDS-PAGE and yields were quantified by
densitometric measures of band intensities. To assess whether the
N-terminal methionine residues were properly cleaved, N-terminal
peptide sequences of the a-a n db-chain subunits were determined
by means of Edman degradation. To prepare samples for peptide
sequencing, the a-a n db-globin monomers were separated by
means of Acid-Urea-Triton (AUT) polyacrylamide gel electropho-
resis [33], and were then transferred to PVDF membrane. The
efficacy of the MAP enzyme in cleaving the N-terminal methionine
residues was optimized by systematically altering the induction
temperature, the induction time, and E. coli expression strain.
Large Scale rHb expression
The pGM-HaHb and pGM-LaLb plasmids were initially trans-
formed into the E. coli strain JM109 [34]. Based on results of our
optimization experiments (see Results), the plasmid vectors were
subsequently transformed into the JM109 (DE3) cells for large-scale
production of rHbs. The pCO-MAP expression plasmid was co-
transformed with the pGM-HaHb and pGM-LaLb plasmids. The E.
coli cells were grown overnight in 2xYT medium with supplemented
ampicillin(100 mg/ml)andkanamycin(50 mg/ml)at37uCinanorbital
shaker at 200 rpm. A 5 ml inoculum of the overnight culture was
added to 250 ml of fresh TB medium with a final volume of 50 mg/ml
ampicillin and kanamycin in a 1000 ml conical flask. Production was
scaled-up in batches of 4 to 6 flasks containing 1–1.5 liter of TB
medium. The cells were grown at 37uC in an orbital shaker at 200 rpm
until the absorbance reached 0.6–0.8 at 600 nm. The cells were
induced with 0.2 mM IPTG and were then supplemented with hemin
(50 mg/ml) and glucose (20 g/L). The cells were then subsequently
grown at 28uC for 16 hr in an orbital shaker at 200 rpm.
Purification of rHb
The induced culture was saturated with CO for 15 min and the
bacterial cells were harvested by centrifugation and stored frozen
at 280uC. The cells were resuspended in lysis buffer (3 ml/g of
cells), consisting of 50 mM Tris base, 1 mM EDTA, 0.5 mM
Figure 2. SDS-PAGE (20%) image showing the purified rHb isoforms. Lane BHb, Bovine Hb standard; Lane M, BioRad size standards; Lane 1,
HH crude lysate; Lane 2, HH clarified fraction after dialysis; Lane 3, HH purified fraction; Lane 4, LL crude lysate; Lane 5, LL clarified fraction after
dialysis; Lane 6, LL purified fraction; Lane NaHb, Native Hb from deer mouse blood.
doi:10.1371/journal.pone.0020176.g002
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along with the lysis buffer prior to sonication. The E. coli cells were
sonicated with 10 sec pulse and a 20 sec pause on ice bath with 3.0
output duty for 15 min. Nucleic acids were precipitated by adding
polyethyleneimine solution to a final concentration of 0.5 to 1%.
The crude lysates were centrifuged at 15,000 g for 45 min at 4uC,
and the clarified supernatants were then dialyzed overnight against
CO saturated Tris-TETA buffer (20 mM Tris-HCl and 0.1 mM
triethylenetetraamine, pH 7.4). The dialysed samples were
centrifuged at 15,000 g for 30 min at 4uC and the supernatants
were used for further purification. Recombinant Hbs were purified
by means of HPLC using Q-Sepharose (anion-exchange) followed
by SP-Sepharose (cation-exchange) pre-packed columns. The Q-
Sepharose column was equilibrated with 20 mM Tris-HCl and
0.1 mM triethylenetetraamine, pH 8.3, and the bound rHbs were
eluted by a linear gradient of 0 to 160 mM NaCl in Tris-TETA
buffer pH 8.3. The eluted fractions were dialyzed with 10 mM
sodium phosphate buffer at pH 7.2 and were concentrated with
YM-30 centrifuge filter. The concentrated fractions were passed
through SP-Sepharose column equilibrated with 10 mM sodium
phosphate buffer at pH 7.2. The bound rHbs were eluted with a
linear gradient of equilibration buffer versus 10 mM sodium
phosphate buffer at pH 8.0 and concentrated with ultra filtration
and stored at 280uC in aliquots with ,0.5–1 mM heme. The
qualities of the purified rHb samples were analyzed by 20% SDS-
PAGE (Figure 2). Absorbance of the collected fractions was
measured at 415 nm in a spectrophotometer (Beckman Coulter).
Functional analysis of rHbs
Using the purified rHb samples, absorbance spectra of oxy,
deoxy (obtained by adding a small amount of solid dithionite), and
CO derivatives were measured at 450–600 nm to confirm that the
absorbance maxima corresponded to those of native Hb. O2-
binding equilibria of rHb solutions (0.2 mM heme) were measured
at 37uC and in 0.1 M Hepes, pH 7.4, in the absence (stripped) and
presence of added cofactors (0.1 M KCl
2, and/or 2,3-diphospho-
glycerate [DPG] at 2.0-fold molar excess over rHb tetramers [29])
as previously described [35,36]. The measurements were con-
ducted by using a modified diffusion chamber where changes in
absorbance are recorded during stepwise changes in the O2
tension of equilibration gases. Experimental measures of P50 (O2
tension at half-saturation) and of the cooperativity coefficient n50
were obtained from the zero-intercept and the slope of Hill plots
(log(Y/(12Y)) vs. logPO2, respectively, where Y is the fractional
O2 saturation.
Results and Discussion
We initially tried to optimize the deer mouse rHbs using the
protocol of Shen et al. [22]. In contrast to results obtained with
human Hb (HbA), the deer mouse Hbs were expressed mostly in
the insoluble fraction. Tetramers that incorporated the Ha subunit
were characterized by an especially low solubility. The observed
solubilities of the two deer mouse rHbs were consistent with in silico
predictions using the method of Wilkinson and Harrison [37].
Using this same in silico method, we found that a- and b-chain Hbs
from a diverse array of vertebrate species span a broad range of
predicted solubilities (Table S1). These results suggest that
obtaining adequate yields of soluble rHb may represent a chief
obstacle to the experimental study of rHbs from many non-human
animals.
Our experimental results indicate that the yield of soluble rHb
and the efficiency of heme incorporation vary among different E.
Figure 3. Variation in the efficiency of MAP enzyme in cleaving N-terminal methionine residues from the a- and b-chain subunits of
purified HH rHb. The relative fractions of methionine and valine in the N-terminal residue positions are shown for three experimental conditions:
(A) BL21Star
TM (DE3) at 12uC for 24 hr, (B) BL21Star
TM (DE3) at 30uC for 4 hr with co-expression of pCO-MAP expression plasmid, and (C) JM109 (DE3)
at 28uC for 16 hr with co-expression of pCO-MAP expression plasmid. The efficiency of the MAP enzyme in cleaving the N-terminal methione residues
from the a- and b-chain subunits is indicated by the relative fraction of methionine vs. valine in the N-terminal residue position. When the percentage
of globin chains with NA1 valine exceeds 95%, this indicates that the post-translational modification has been carried out properly.
doi:10.1371/journal.pone.0020176.g003
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enhance the quality and quantity of rHb production. Of the five E.
coli expression strains that we tested, BL21Star
TM (DE3) produced
the highest yield of soluble rHb (Figure S1 a and S1 b). Yields
can be further enhanced by using the right combination of
induction temperature and induction time. Using the pGM-HaHb
plasmid in the BL21Star
TM (DE3) expression strain, we found that
the highest yield of soluble rHb – relative to the insoluble fraction -
was produced at low temperature with an extended induction time
(12uC for 24 hr; Figure S1 c and S1 d). When supplemented
with a rich medium, E. coli can continue to maintain a balanced
growth in temperatures ranging from 10 to 49uC [38]. At low
temperature, cold shock proteins such as CsdA, RbfA and CspA
will be induced and they play important roles in protein synthesis
[39,40,41]. Our preliminary results suggest that induction of the
BL21Star
TM (DE3) expression strain at 12uC for 24 hr yields good
quantity of rHbs in the soluble fraction. We also assessed whether
the N-terminal methionine residues were properly cleaved from
the a- and b-chain subunits of the rHbs. To do this, the
recombinant globin chains were separated by means of AUT gel
electrophoresis and were then subjected to N-terminal peptide
sequencing. We established an optimal culture condition to
enhance the MAP activity without affecting the solubility of
recombinant globin chains. We compared three combinations of
induction temperature, induction time and expression strains: A)
BL21Star
TM (DE3) at 12uC for 24 hr, B) BL21Star
TM (DE3) at
30uC for 4 hr with co-expression of pCO-MAP expression
plasmid, C) JM109 (DE3) at 28uC for 16 hr with co-expression
of pCO-MAP expression plasmid. The N-terminal peptide
sequencing revealed that the rHbs expressed in JM109 (DE3) at
28uC for 16 hr with an additional copy of the MAP gene had the
lowest fraction of intact N-terminal methionine residues in both
the a- and b-chains (i.e., the post-translational processing was the
most efficient) (Figure 3). Our results also revealed that the
JM109 (DE3) strain generally produces rHb with a higher
efficiency of heme incorporation compared to the BL21Star
TM
(DE3) strain. In general, an increased induction temperature
enhances MAP enzyme activity but decreases the solubility of
recombinant globin chains. Thus, the optimal expression condi-
tions strike a balance between protein yield and proper post-
translational processing.
Relative to the LL rHb, the O2-binding experiments revealed
that the HH rHb has a higher intrinsic O2 affinity (i.e., lower
P50(stripped)) under the buffer conditions investigated (Figure 4) but
similar affinity in the presence of anionic cofactors. The measured
difference in intrinsic O2-affinity between the HH and LL rHbs is
slightly larger than the measured O2-affinity differences between
stripped red cell lysates from high- and low-altitude deer mice
[30,31]. The stripped HH and LL rHbs exhibited P50 values of 4.5
and 5.7 Torr and n50 values of 1.8 and 2.1, respectively (37uC,
0.1 M Hepes buffer, pH 7.4, heme concentration=0.2 mM).
Under identical experimental conditions, the stripped red cell
lysates of high- and low-altitude mice exhibited mean P50 values of
7.4 and 7.9 Torr and mean n50 values of 2.1 and 2.3, respectively
[31]. Individual deer mice generally express at least 3–4 distinct
Hb components that contain different combinations of amino acid
mutations in both the a- and b-chain subunits [30,31], but the
most common native Hb types in mice from high- and low-altitude
have a- and b-chain primary structures that are similar (or
identical) to those of the HH and LL rHbs, respectively. Although
the red cells of high-altitude deer mice contain a preponderance of
Hb components that are highly similar to the HH rHb, such
components are typically co-expressed with other a- and/or b-
chain isoforms that bear closer similarities to the LL rHb. Given
the heterogeneous mix of distinct Hb types in the red cells of deer
mice, we would not expect an exact match between P50 values for
the composite hemolysates and those of isolated Hb components.
Nonetheless, as expected, we do see a clear correspondence in the
direction and magnitude of O2 affinity differences in the
comparison between HH and LL rHbs and in the comparison
between red cell lysates from high- and low-altitude mice. Because
of the high level of Hb heterogeneity in the red cells of deer mice,
Figure 4. O2-binding properties of purified deer mouse rHbs. Panels A and B show O2 equilibrium curves for purified rHbs HH and LL,
respectively. The rHbs HH and LL were expressed in the JM109 (DE3) E. coli strain at 28uC for 16 hr with co-expression of the pCO-MAP plasmid. O2-
binding measurements were conducted at pH 7.4 at 37uC in presence and absence of allosteric cofactors (0.1 M Cl
2, 0.1 M Hepes, 2.0-fold ratio DPG /
rHb tetramers and 0.2 mM heme). Horizontal lines denote the half-saturation value for each rHb.
doi:10.1371/journal.pone.0020176.g004
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recombinantly expressed Hbs will provide the most powerful
means of identifying the specific amino acid mutations that are
responsible for the observed differences in intrinsic O2 affinity
between the high- and low-altitude Hb variants.
In summary, we identified combinations of expression condi-
tions that can be expected to improve the qualitative yield of rHbs
with low intrinsic solubilities in E. coli. This protocol should prove
useful for the experimental study of rHbs in many non-human
animals. Previous methods for expressing rHbs in E. coli involved
the independent production of a- and b-chain subunits, followed
by a second step to ensure proper heme incorporation during the
assembly of the a2b2 tetramer. One of the chief advantages of our
protocol is that we can express soluble rHb without co-expressing
molecular chaperones like AHSP, and without the need for
additional reconstitution or heme-incorporation steps. Moreover,
our plasmid construct contains a combination of four unique
restriction enzyme cut-sites flanking the a- and b-globin genes,
which facilitates the swapping of alternative a- and b-globin
variants to produce different tetrameric combinations.
Supporting Information
Figure S1 Optimization of HH rHb expression in E.
coli. (a) 16% SDS-PAGE image showing the expression profile of
HH rHbs in different E. coli strains. Lane M, BioRad size
standards; Lanes SF and ISF correspond to the soluble and
insoluble fraction of rHbs in each of five different E. coli strains: (A)
JM109 (DE3), (B) BL21 (DE3) pLysS, (C) BL21Star
TM (DE3), (D)
BLR (DE3), (E) Origami
TM (DE3); Lane BHb, Bovine Hb
standard; (b) Densitometric analysis of rHbs in the soluble and
insoluble fractions in different E. coli strains. (c) 16% SDS-PAGE
image showing the expression profile of HH rHbs at different
conditions. Lane M, BioRad size standards; Lanes SF and ISF
correspond to the soluble and insoluble fraction of rHbs under
four different expression conditions: (1) 12uC for 24 hr, (2) 25uC
for 16 hr, (3) 30uC for 4 hr, (4) 37uC for 4 hr; Lane BHb, Bovine
Hb standard. (d) Densitometric analysis of rHbs at different
expression conditions. Graph shows the soluble versus insoluble
fraction ratios on the y axis, different expression conditions on the
x axis.
(EPS)
Table S1 Table showing in silco predictions of the
intrinsic solubilities of hemoglobins from a phylogenet-
ically diverse set of vertebrate species.
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